NOREPINEPHRINE BITARTRATE injection United States - English - NLM (National Library of Medicine)

norepinephrine bitartrate injection

hikma pharmaceuticals usa inc. - norepinephrine bitartrate (unii: ify5pe3zrw) (norepinephrine - unii:x4w3enh1cv) - norepinephrine bitartrate injection, usp is indicated to raise blood pressure in adult patients with severe, acute hypotension. none. limited published data consisting of a small number of case reports and multiple small trials involving the use of norepinephrine in pregnant women at the time of delivery have not identified an increased risk of major birth defects, miscarriage or adverse maternal or fetal outcomes. there are risks to the mother and fetus from hypotension associated with septic shock, myocardial infarction and stroke which are medical emergencies in pregnancy and can be fatal if left untreated. (see clinical considerations ). in animal reproduction studies, using high doses of intravenous norepinephrine resulted in lowered maternal placental blood flow. clinical relevance to changes in the human fetus is unknown since the average maintenance dose is ten times lower (see data) . increased fetal reabsorptions were observed in pregnant hamsters after receiving daily injections at approximately 2

NOREPINEPHRINE BITARTRATE injection, solution, concentrate United States - English - NLM (National Library of Medicine)

norepinephrine bitartrate injection, solution, concentrate

amneal pharmaceuticals llc - norepinephrine bitartrate (unii: ify5pe3zrw) (norepinephrine - unii:x4w3enh1cv) - norepinephrine bitartrate injection is indicated to raise blood pressure in adult patients with severe, acute hypotension. none. risk summary limited published data consisting of a small number of case reports and multiple small trials involving the use of norepinephrine in pregnant women at the time of delivery have not identified an increased risk of major birth defects, miscarriage or adverse maternal or fetal outcomes. there are risks to the mother and fetus from hypotension associated with septic shock, myocardial infarction and stroke which are medical emergencies in pregnancy and can be fatal if left untreated. (see clinical considerations ). in animal reproduction studies, using high doses of intravenous norepinephrine resulted in lowered maternal placental blood flow. clinical relevance to changes in the human fetus is unknown since the average maintenance dose is ten times lower (see data) . increased fetal reabsorptions were observed in pregnant hamsters after receiving daily injections at approxim

EPINEPHRINE injection, solution United States - English - NLM (National Library of Medicine)

epinephrine injection, solution

sina health inc - epinephrine (unii: ykh834o4bh) (epinephrine - unii:ykh834o4bh) - epinephrine is used to relieve respiratory distress due to bronchospasm, to provide rapid relief of hypersensitivity reactions to drugs and other allergens, and to prolong the action of anesthetics. its cardiac effects may be of use in restoring cardiac rhythm in cardiac arrest due to various causes, but it is not used in cardiac failure or in hemorrhagic, traumatic, or cardiogenic shock. epinephrine is used as a hemostatic agent. it is also used in treating mucosal congestion of hay fever, rhinitis, and acute sinusitis; to relieve bronchial asthmatic paroxysms; in syncope due to complete heart block or carotid sinus hypersensitivity; for symptomatic relief of serum sickness, urticaria, angioneurotic edema; for resuscitation in cardiac arrest following anesthetic accidents; in simple (open angle) glaucoma; for relaxation of uterine musculature and to inhibit uterine contractions. epinephrine injection can be utilized to prolong the action of anesthetics used in local and regional anesthesia. epinephrine is co

NOREPINEPHRINE BITARTRATE injection, solution, concentrate United States - English - NLM (National Library of Medicine)

norepinephrine bitartrate injection, solution, concentrate

sandoz inc - norepinephrine bitartrate (unii: ify5pe3zrw) (norepinephrine - unii:x4w3enh1cv) - norepinephrine bitartrate injection is indicated to raise blood pressure in adult patients with severe, acute hypotension. none. risk summary limited published data consisting of a small number of case reports and multiple small trials involving the use of norepinephrine in pregnant women at the time of delivery have not identified an increased risk of major birth defects, miscarriage or adverse maternal or fetal outcomes. there are risks to the mother and fetus from hypotension associated with septic shock, myocardial infarction and stroke which are medical emergencies in pregnancy and can be fatal if left untreated ( see clinical considerations ). in animal reproduction studies, using high doses of intravenous norepinephrine resulted in lowered maternal placental blood flow. clinical relevance to changes in the human fetus is unknown since the average maintenance dose is ten times lower ( see data ). increased fetal reabsorptions were observed in pregnant hamsters after receiving

Noradrenaline (Norepinephrine) Aguettant 1 mg/ml inf. sol. (conc.) i.v. amp. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

noradrenaline (norepinephrine) aguettant 1 mg/ml inf. sol. (conc.) i.v. amp.

laboratoire aguettant - norepinephrine hydrogen tartrate 2 mg/ml - eq. norepinephrine 1 mg/ml - concentrate for solution for infusion - 1 mg/ml - norepinephrine bitartrate (= noradrenaline acid tartrate) 2 mg/ml - norepinephrine

Noradrenaline (Norepinephrine) Aguettant 1 mg/ml inf. sol. (conc.) i.v. amp. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

noradrenaline (norepinephrine) aguettant 1 mg/ml inf. sol. (conc.) i.v. amp.

laboratoire aguettant - norepinephrine hydrogen tartrate 2 mg/ml - eq. norepinephrine 1 mg/ml - concentrate for solution for infusion - 1 mg/ml - norepinephrine bitartrate (= noradrenaline acid tartrate) 2 mg/ml - norepinephrine

Noradrenaline (Norepinephrine) Kalceks 1 mg/ml inf. sol. (conc.) i.v. amp. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

noradrenaline (norepinephrine) kalceks 1 mg/ml inf. sol. (conc.) i.v. amp.

as kalceks a.s. - norepinephrine hydrogen tartrate 2 mg/ml - eq. norepinephrine 1 mg/ml - concentrate for solution for infusion - 1 mg/ml - norepinephrine bitartrate (= noradrenaline acid tartrate) 2 mg/ml - norepinephrine

Noradrenaline (Norepinephrine) Kalceks 1 mg/ml inf. sol. (conc.) i.v. amp. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

noradrenaline (norepinephrine) kalceks 1 mg/ml inf. sol. (conc.) i.v. amp.

as kalceks a.s. - norepinephrine hydrogen tartrate 2 mg/ml - eq. norepinephrine 1 mg/ml - concentrate for solution for infusion - 1 mg/ml - norepinephrine bitartrate (= noradrenaline acid tartrate) 2 mg/ml - norepinephrine

Noradrenaline (Norepinephrine) Kalceks 1 mg/ml inf. sol. (conc.) i.v. amp. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

noradrenaline (norepinephrine) kalceks 1 mg/ml inf. sol. (conc.) i.v. amp.

as kalceks a.s. - norepinephrine hydrogen tartrate 2 mg/ml - eq. norepinephrine 1 mg/ml - concentrate for solution for infusion - 1 mg/ml - norepinephrine bitartrate (= noradrenaline acid tartrate) 2 mg/ml - norepinephrine

Noradrenaline (Norepinephrine) Kalceks 1 mg/ml inf. sol. (conc.) i.v. amp. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

noradrenaline (norepinephrine) kalceks 1 mg/ml inf. sol. (conc.) i.v. amp.

as kalceks a.s. - norepinephrine hydrogen tartrate 2 mg/ml - eq. norepinephrine 1 mg/ml - concentrate for solution for infusion - 1 mg/ml - norepinephrine bitartrate (= noradrenaline acid tartrate) 2 mg/ml - norepinephrine